Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 19Thyroid Neoplasms 6Glioma 6Thyroid Carcinoma, Anaplastic 5Multiple Myeloma 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Thyroid Cancer, Papillary 3Hematologic Neoplasms 3Skin Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Lymphoma 2Lung Neoplasms 2Histiocytosis, Langerhans-Cell 2Glioblastoma 2Colonic Neoplasms 2Brain Neoplasms 2Astrocytoma 2Adenocarcinoma, Follicular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Stomach Neoplasms 1Spinocerebellar Degenerations 1Sarcoma 1

Interventions

pembrolizumab 16Nivolumab 15Ipilimumab 12cemiplimab 10aldesleukin 6Interleukin-2 6Cyclophosphamide 6fludarabine 5fludarabine phosphate 4encorafenib 4binimetinib 4Blood Specimen Collection 4avelumab 3Sirolimus 3trametinib 2spartalizumab 2lifileucel 2dabrafenib 2atezolizumab 2Vemurafenib 2Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Prednisone 2Niacinamide 2Exercise 2Everolimus 2Dermoscopy 2Biopsy 2urelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Neoplasms × dabrafenib × 1 year × Clear all
NCT02967692 2025-09-18

COMBI-i

Novartis

Phase 3 Terminated
568 enrolled 28 charts
Dermatologic

Melanoma, Skin Neoplasms

NCT07092670 2025-09-05

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Intergruppo Melanoma Italiano

Recruiting
270 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡